News & Events

Biocytogen and LiberoThera Enter into Strategic Collaboration Agreement

Beijing, China and Tokyo, Japan, February 1st, 2021 – Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) and LiberoThera Co.,Ltd (“LiberoThera”) announced today that they have entered into…

Read more
Biocytogen Subsidiary Eucure Biopharma Reports First Patient Enrolled in anti-CTLA4 Phase I Trial in China

BOSTON and BEIJING, Jan. 26, 2021 /PRNewswire/ -- Eucure Biopharma, a subsidiary of Biocytogen, announced the first patient enrollment for a Phase I clinical trial in China to evaluate the safety, tolerability,…

Read more
Beijing Biocytogen Company Name Change Annuncement

Effective December 29th, 2020, our parent company name has officially changed from Beijing Biocytogen Co., Ltd. to Biocytogen Pharmaceuticals (Beijing) Co., Ltd. There is no…

Read more
Biocytogen Enters into RenMab™/RenLite™ Licensing Agreement with Xencor

Xencor to use RenLite™ Fully Human Antibody Mouse Platform to discover novel antibody drugs WAKEFIELD, Mass. and BEIJING, Dec. 7, 2020 /PRNewswire/--Beijing Biocytogen Co., Ltd. , Biocytogen Boston…

Read more
Biocytogen Teams With Ina Research To Boost Presence In Japan

Beijing, China and Nagano, Japan; November 30, 2020-Beijing Biocytogen Co., Ltd. (hereinafter “Biocytogen”) announced today that it has entered into a commercial agency agreement with…

Read more
Antibody Engineering & Therapeutics Virtual 2020

Agenda  Book Now Presentation: Advancing Therapeutic Antibody discovery using RenMab/RenLite/RenMab KO immunoglobulin humanized mouse platforms Speaker: Li Hui, PhD, MD, Scientific Director of Biocytogen Boston…

Read more
Festival of Biologics Basel 2020

Therapeutic Antibody Hit Generation Using Fully Human Antibody Transgenic Mice RenMab™ and RenLite™ Speaker: Qingcong Lin, CEO of Biocytogen Boston Corp Time: 1:30pm GMT/8:30am ET,…

Read more
Celebrating World CRISPR Day

Please fill out the form on the left side to consult with our gene editing specialist. To learn more, download gene editing services brochure.

Read more
Immuno-Oncology Summit Virtual Summit 2020

About the Immuno-Oncology Summit Over the past 8 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing…

Read more
Emerging biotechnology company Biocytogen raised 142 million dollars (USD) in support of Project Integrum

BEIJING and BOSTON, Sept. 24, 2020 /PRNewswire/ -- In August, Beijing Biocytogen Biotechnology Co., Ltd. ("Biocytogen") announced acquisition of Eucure Biopharma, which established Biocytogen as a clinical stage…

Read more
Back to top